View Future GrowthBio Planet 過去の業績過去 基準チェック /46Bio Planetの収益は年間平均-5.7%の割合で減少していますが、 Consumer Retailing業界の収益は年間 増加しています。収益は年間7.3% 9.8%割合で 増加しています。 Bio Planetの自己資本利益率は19.8%であり、純利益率は2%です。主要情報-5.74%収益成長率-19.38%EPS成長率Consumer Retailing 業界の成長10.52%収益成長率9.80%株主資本利益率19.85%ネット・マージン2.02%次回の業績アップデート26 May 2026最近の業績更新お知らせ • Aug 22Bio Planet S.A. to Report First Half, 2025 Results on Sep 25, 2025Bio Planet S.A. announced that they will report first half, 2025 results on Sep 25, 2025Reported Earnings • Oct 01Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: zł63.8m (up 5.0% from 2Q 2023). Net income: zł47.0k (down 88% from 2Q 2023). Profit margin: 0.1% (down from 0.6% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance.Reported Earnings • May 29First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: zł76.3m (up 11% from 1Q 2023). Net income: zł1.26m (down 2.1% from 1Q 2023). Profit margin: 1.7% (down from 1.9% in 1Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.Reported Earnings • Apr 26Full year 2023 earnings releasedFull year 2023 results: Revenue: zł254.5m (up 26% from FY 2022). Net income: zł945.0k (up 63% from FY 2022). Profit margin: 0.4% (up from 0.3% in FY 2022). The increase in margin was driven by higher revenue.お知らせ • Dec 09+ 3 more updatesBio Planet S.A. to Report Q1, 2024 Results on May 24, 2024Bio Planet S.A. announced that they will report Q1, 2024 results on May 24, 2024Reported Earnings • Nov 27Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: zł56.9m (up 25% from 3Q 2022). Net loss: zł932.0k (loss narrowed 16% from 3Q 2022).すべての更新を表示Recent updatesお知らせ • Apr 22Bio Planet S.A., Annual General Meeting, May 15, 2026Bio Planet S.A., Annual General Meeting, May 15, 2026, at 10:00 Central European Standard Time.お知らせ • Apr 21Bio Planet S.A. announces Annual dividend, payable on September 18, 2026Bio Planet S.A. announced Annual dividend of PLN 0.6300 per share payable on September 18, 2026, ex-date on June 23, 2026 and record date on June 24, 2026.お知らせ • Aug 22Bio Planet S.A. to Report First Half, 2025 Results on Sep 25, 2025Bio Planet S.A. announced that they will report first half, 2025 results on Sep 25, 2025お知らせ • Jun 01Bio Planet S.A. announces Annual dividend, payable on July 28, 2025Bio Planet S.A. announced Annual dividend of PLN 0.1000 per share payable on July 28, 2025, ex-date on July 11, 2025 and record date on July 14, 2025.New Risk • Nov 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.9x net interest cover). Earnings have declined by 27% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Market cap is less than US$100m (€11.2m market cap, or US$11.9m).New Risk • Oct 06New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 0.9x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.9x net interest cover). Earnings have declined by 27% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€12.3m market cap, or US$13.5m).Reported Earnings • Oct 01Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: zł63.8m (up 5.0% from 2Q 2023). Net income: zł47.0k (down 88% from 2Q 2023). Profit margin: 0.1% (down from 0.6% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance.Reported Earnings • May 29First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: zł76.3m (up 11% from 1Q 2023). Net income: zł1.26m (down 2.1% from 1Q 2023). Profit margin: 1.7% (down from 1.9% in 1Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.Reported Earnings • Apr 26Full year 2023 earnings releasedFull year 2023 results: Revenue: zł254.5m (up 26% from FY 2022). Net income: zł945.0k (up 63% from FY 2022). Profit margin: 0.4% (up from 0.3% in FY 2022). The increase in margin was driven by higher revenue.お知らせ • Dec 09+ 3 more updatesBio Planet S.A. to Report Q1, 2024 Results on May 24, 2024Bio Planet S.A. announced that they will report Q1, 2024 results on May 24, 2024Valuation Update With 7 Day Price Move • Dec 07Investor sentiment improves as stock rises 19%After last week's 19% share price gain to €2.78, the stock trades at a trailing P/E ratio of 63.7x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe. Total returns to shareholders of 39% over the past year.Reported Earnings • Nov 27Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: zł56.9m (up 25% from 3Q 2022). Net loss: zł932.0k (loss narrowed 16% from 3Q 2022).New Risk • Sep 26New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 0.7x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.7x net interest cover). Share price has been highly volatile over the past 3 months (9.1% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.2% net profit margin). Market cap is less than US$100m (€10.4m market cap, or US$10.9m).Reported Earnings • Sep 23Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: zł60.7m (up 30% from 2Q 2022). Net income: zł394.0k (up zł529.0k from 2Q 2022). Profit margin: 0.6% (up from net loss in 2Q 2022).New Risk • Jun 15New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 1.1x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.1x net interest cover). Market cap is less than US$10m (€8.28m market cap, or US$9.05m). Minor Risk Share price has been volatile over the past 3 months (9.2% average weekly change).New Risk • Jun 11New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.12m (US$9.80m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (€9.12m market cap, or US$9.80m). Minor Risk Share price has been volatile over the past 3 months (9.0% average weekly change).お知らせ • May 27Bio Planet S.A., Annual General Meeting, Jun 21, 2023Bio Planet S.A., Annual General Meeting, Jun 21, 2023, at 10:00 Central European Standard Time.Valuation Update With 7 Day Price Move • May 15Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €3.04, the stock trades at a trailing P/E ratio of 77.5x. Average trailing P/E is 16x in the Consumer Retailing industry in Europe. Total returns to shareholders of 22% over the past year.Reported Earnings • Apr 21Full year 2022 earnings releasedFull year 2022 results: Revenue: zł201.5m (down 1.9% from FY 2021). Net income: zł581.0k (down 84% from FY 2021). Profit margin: 0.3% (down from 1.8% in FY 2021).Valuation Update With 7 Day Price Move • Feb 07Investor sentiment improves as stock rises 26%After last week's 26% share price gain to €2.63, the stock trades at a trailing P/E ratio of 77.8x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe. Total loss to shareholders of 46% over the past year.Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improved over the past weekAfter last week's 17% share price gain to €2.33, the stock trades at a trailing P/E ratio of 69.2x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe. Total loss to shareholders of 56% over the past year.お知らせ • Jan 12+ 3 more updatesBio Planet S.A. to Report Q1, 2023 Results on May 26, 2023Bio Planet S.A. announced that they will report Q1, 2023 results on May 26, 2023Reported Earnings • Nov 27Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: zł45.5m (up 4.2% from 3Q 2021). Net loss: zł1.11m (down zł1.28m from profit in 3Q 2021).Valuation Update With 7 Day Price Move • Nov 17Investor sentiment improved over the past weekAfter last week's 19% share price gain to €2.19, the stock trades at a trailing P/E ratio of 18.8x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 65% over the past year.Valuation Update With 7 Day Price Move • Oct 25Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €1.68, the stock trades at a trailing P/E ratio of 14.5x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 74% over the past year.お知らせ • Sep 28Bio Pole Spolka Z Ograniczona Odpowiedzialnoscia acquired 8% stake in Bio Planet S.A. (WSE:BIP) from ORGANIC Farma Zdrowia S.A. (WSE:ORG).Bio Pole Spolka Z Ograniczona Odpowiedzialnoscia acquired 8% stake in Bio Planet S.A. (WSE:BIP) from ORGANIC Farma Zdrowia S.A. (WSE:ORG) on September 26, 2022.Bio Pole Spolka Z Ograniczona Odpowiedzialnoscia completed the acquisition of 8% stake in Bio Planet S.A. (WSE:BIP) from ORGANIC Farma Zdrowia S.A. (WSE:ORG) on September 26, 2022.Reported Earnings • Sep 25Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: zł46.7m (down 4.4% from 2Q 2021). Net loss: zł135.0k (down 116% from profit in 2Q 2021).Valuation Update With 7 Day Price Move • Sep 01Investor sentiment improved over the past weekAfter last week's 42% share price gain to €2.97, the stock trades at a trailing P/E ratio of 16.3x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 48% over the past year.Upcoming Dividend • Jul 29Upcoming dividend of zł0.36 per shareEligible shareholders must have bought the stock before 05 August 2022. Payment date: 22 August 2022. Trailing yield: 3.1%. Lower than top quartile of German dividend payers (4.5%). Lower than average of industry peers (4.4%).Valuation Update With 7 Day Price Move • Jun 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to €2.91, the stock trades at a trailing P/E ratio of 9.3x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 63% over the past year.お知らせ • May 20Bio Planet S.A., Annual General Meeting, Jun 14, 2022Bio Planet S.A., Annual General Meeting, Jun 14, 2022, at 10:00 Central European Standard Time.Valuation Update With 7 Day Price Move • May 03Investor sentiment deteriorated over the past weekAfter last week's 24% share price decline to €3.08, the stock trades at a trailing P/E ratio of 10.4x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe.Reported Earnings • Nov 10Third quarter 2021 earnings releasedThe company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: zł43.6m (down 2.0% from 3Q 2020). Net income: zł165.0k (down 68% from 3Q 2020). Profit margin: 0.4% (down from 1.1% in 3Q 2020). The decrease in margin was driven by lower revenue.Reported Earnings • Nov 10Third quarter 2021 earnings releasedThe company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: zł43.6m (down 2.0% from 3Q 2020). Net income: zł165.0k (down 68% from 3Q 2020). Profit margin: 0.4% (down from 1.1% in 3Q 2020). The decrease in margin was driven by lower revenue.Valuation Update With 7 Day Price Move • Jul 18Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to zł6.30, the stock trades at a trailing P/E ratio of 15.4x. Average trailing P/E is 20x in the Consumer Retailing industry in Europe.収支内訳Bio Planet の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史DB:8WS 収益、費用、利益 ( )PLN Millions日付収益収益G+A経費研究開発費31 Dec 2531160030 Sep 25302574030 Jun 25293473031 Mar 25284372031 Dec 24279272030 Sep 24272170030 Jun 24265168031 Mar 24262167031 Dec 23255163030 Sep 23240158030 Jun 23228055031 Mar 23214052031 Dec 22201148030 Sep 22202048030 Jun 22201247031 Mar 22203347031 Dec 21205447030 Sep 21205547030 Jun 21206547031 Mar 21207646031 Dec 20204545030 Sep 20191541030 Jun 20181439031 Mar 20168336031 Dec 19153234030 Sep 19146132030 Jun 19141131031 Mar 19134029031 Dec 18128028030 Sep 18126028030 Jun 18125027031 Mar 18125027031 Dec 17123126030 Sep 17121125030 Jun 17121224031 Mar 17119223031 Dec 16113122030 Sep 16108122030 Jun 16102121031 Mar 1694120031 Dec 1586218030 Sep 1579217030 Jun 15732160質の高い収益: 8WSは 高品質の収益 を持っています。利益率の向上: 8WSの現在の純利益率 (2%)は、昨年(0.7%)よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: 8WSの収益は過去 5 年間で年間5.7%減少しました。成長の加速: 8WSの過去 1 年間の収益成長率 ( 214% ) は、5 年間の平均 ( 年間-5.7%を上回っています。収益対業界: 8WSの過去 1 年間の収益成長率 ( 214% ) はConsumer Retailing業界2.8%を上回りました。株主資本利益率高いROE: 8WSの 自己資本利益率 ( 19.8% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YConsumer-retailing 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/25 09:46終値2026/05/22 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Bio Planet S.A. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Aug 22Bio Planet S.A. to Report First Half, 2025 Results on Sep 25, 2025Bio Planet S.A. announced that they will report first half, 2025 results on Sep 25, 2025
Reported Earnings • Oct 01Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: zł63.8m (up 5.0% from 2Q 2023). Net income: zł47.0k (down 88% from 2Q 2023). Profit margin: 0.1% (down from 0.6% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance.
Reported Earnings • May 29First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: zł76.3m (up 11% from 1Q 2023). Net income: zł1.26m (down 2.1% from 1Q 2023). Profit margin: 1.7% (down from 1.9% in 1Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.
Reported Earnings • Apr 26Full year 2023 earnings releasedFull year 2023 results: Revenue: zł254.5m (up 26% from FY 2022). Net income: zł945.0k (up 63% from FY 2022). Profit margin: 0.4% (up from 0.3% in FY 2022). The increase in margin was driven by higher revenue.
お知らせ • Dec 09+ 3 more updatesBio Planet S.A. to Report Q1, 2024 Results on May 24, 2024Bio Planet S.A. announced that they will report Q1, 2024 results on May 24, 2024
Reported Earnings • Nov 27Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: zł56.9m (up 25% from 3Q 2022). Net loss: zł932.0k (loss narrowed 16% from 3Q 2022).
お知らせ • Apr 22Bio Planet S.A., Annual General Meeting, May 15, 2026Bio Planet S.A., Annual General Meeting, May 15, 2026, at 10:00 Central European Standard Time.
お知らせ • Apr 21Bio Planet S.A. announces Annual dividend, payable on September 18, 2026Bio Planet S.A. announced Annual dividend of PLN 0.6300 per share payable on September 18, 2026, ex-date on June 23, 2026 and record date on June 24, 2026.
お知らせ • Aug 22Bio Planet S.A. to Report First Half, 2025 Results on Sep 25, 2025Bio Planet S.A. announced that they will report first half, 2025 results on Sep 25, 2025
お知らせ • Jun 01Bio Planet S.A. announces Annual dividend, payable on July 28, 2025Bio Planet S.A. announced Annual dividend of PLN 0.1000 per share payable on July 28, 2025, ex-date on July 11, 2025 and record date on July 14, 2025.
New Risk • Nov 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.9x net interest cover). Earnings have declined by 27% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Market cap is less than US$100m (€11.2m market cap, or US$11.9m).
New Risk • Oct 06New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 0.9x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.9x net interest cover). Earnings have declined by 27% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€12.3m market cap, or US$13.5m).
Reported Earnings • Oct 01Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: zł63.8m (up 5.0% from 2Q 2023). Net income: zł47.0k (down 88% from 2Q 2023). Profit margin: 0.1% (down from 0.6% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance.
Reported Earnings • May 29First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: zł76.3m (up 11% from 1Q 2023). Net income: zł1.26m (down 2.1% from 1Q 2023). Profit margin: 1.7% (down from 1.9% in 1Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.
Reported Earnings • Apr 26Full year 2023 earnings releasedFull year 2023 results: Revenue: zł254.5m (up 26% from FY 2022). Net income: zł945.0k (up 63% from FY 2022). Profit margin: 0.4% (up from 0.3% in FY 2022). The increase in margin was driven by higher revenue.
お知らせ • Dec 09+ 3 more updatesBio Planet S.A. to Report Q1, 2024 Results on May 24, 2024Bio Planet S.A. announced that they will report Q1, 2024 results on May 24, 2024
Valuation Update With 7 Day Price Move • Dec 07Investor sentiment improves as stock rises 19%After last week's 19% share price gain to €2.78, the stock trades at a trailing P/E ratio of 63.7x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe. Total returns to shareholders of 39% over the past year.
Reported Earnings • Nov 27Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: zł56.9m (up 25% from 3Q 2022). Net loss: zł932.0k (loss narrowed 16% from 3Q 2022).
New Risk • Sep 26New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 0.7x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.7x net interest cover). Share price has been highly volatile over the past 3 months (9.1% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.2% net profit margin). Market cap is less than US$100m (€10.4m market cap, or US$10.9m).
Reported Earnings • Sep 23Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: zł60.7m (up 30% from 2Q 2022). Net income: zł394.0k (up zł529.0k from 2Q 2022). Profit margin: 0.6% (up from net loss in 2Q 2022).
New Risk • Jun 15New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 1.1x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.1x net interest cover). Market cap is less than US$10m (€8.28m market cap, or US$9.05m). Minor Risk Share price has been volatile over the past 3 months (9.2% average weekly change).
New Risk • Jun 11New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.12m (US$9.80m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (€9.12m market cap, or US$9.80m). Minor Risk Share price has been volatile over the past 3 months (9.0% average weekly change).
お知らせ • May 27Bio Planet S.A., Annual General Meeting, Jun 21, 2023Bio Planet S.A., Annual General Meeting, Jun 21, 2023, at 10:00 Central European Standard Time.
Valuation Update With 7 Day Price Move • May 15Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €3.04, the stock trades at a trailing P/E ratio of 77.5x. Average trailing P/E is 16x in the Consumer Retailing industry in Europe. Total returns to shareholders of 22% over the past year.
Reported Earnings • Apr 21Full year 2022 earnings releasedFull year 2022 results: Revenue: zł201.5m (down 1.9% from FY 2021). Net income: zł581.0k (down 84% from FY 2021). Profit margin: 0.3% (down from 1.8% in FY 2021).
Valuation Update With 7 Day Price Move • Feb 07Investor sentiment improves as stock rises 26%After last week's 26% share price gain to €2.63, the stock trades at a trailing P/E ratio of 77.8x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe. Total loss to shareholders of 46% over the past year.
Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improved over the past weekAfter last week's 17% share price gain to €2.33, the stock trades at a trailing P/E ratio of 69.2x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe. Total loss to shareholders of 56% over the past year.
お知らせ • Jan 12+ 3 more updatesBio Planet S.A. to Report Q1, 2023 Results on May 26, 2023Bio Planet S.A. announced that they will report Q1, 2023 results on May 26, 2023
Reported Earnings • Nov 27Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: zł45.5m (up 4.2% from 3Q 2021). Net loss: zł1.11m (down zł1.28m from profit in 3Q 2021).
Valuation Update With 7 Day Price Move • Nov 17Investor sentiment improved over the past weekAfter last week's 19% share price gain to €2.19, the stock trades at a trailing P/E ratio of 18.8x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 65% over the past year.
Valuation Update With 7 Day Price Move • Oct 25Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €1.68, the stock trades at a trailing P/E ratio of 14.5x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 74% over the past year.
お知らせ • Sep 28Bio Pole Spolka Z Ograniczona Odpowiedzialnoscia acquired 8% stake in Bio Planet S.A. (WSE:BIP) from ORGANIC Farma Zdrowia S.A. (WSE:ORG).Bio Pole Spolka Z Ograniczona Odpowiedzialnoscia acquired 8% stake in Bio Planet S.A. (WSE:BIP) from ORGANIC Farma Zdrowia S.A. (WSE:ORG) on September 26, 2022.Bio Pole Spolka Z Ograniczona Odpowiedzialnoscia completed the acquisition of 8% stake in Bio Planet S.A. (WSE:BIP) from ORGANIC Farma Zdrowia S.A. (WSE:ORG) on September 26, 2022.
Reported Earnings • Sep 25Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: zł46.7m (down 4.4% from 2Q 2021). Net loss: zł135.0k (down 116% from profit in 2Q 2021).
Valuation Update With 7 Day Price Move • Sep 01Investor sentiment improved over the past weekAfter last week's 42% share price gain to €2.97, the stock trades at a trailing P/E ratio of 16.3x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 48% over the past year.
Upcoming Dividend • Jul 29Upcoming dividend of zł0.36 per shareEligible shareholders must have bought the stock before 05 August 2022. Payment date: 22 August 2022. Trailing yield: 3.1%. Lower than top quartile of German dividend payers (4.5%). Lower than average of industry peers (4.4%).
Valuation Update With 7 Day Price Move • Jun 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to €2.91, the stock trades at a trailing P/E ratio of 9.3x. Average trailing P/E is 13x in the Consumer Retailing industry in Europe. Total loss to shareholders of 63% over the past year.
お知らせ • May 20Bio Planet S.A., Annual General Meeting, Jun 14, 2022Bio Planet S.A., Annual General Meeting, Jun 14, 2022, at 10:00 Central European Standard Time.
Valuation Update With 7 Day Price Move • May 03Investor sentiment deteriorated over the past weekAfter last week's 24% share price decline to €3.08, the stock trades at a trailing P/E ratio of 10.4x. Average trailing P/E is 14x in the Consumer Retailing industry in Europe.
Reported Earnings • Nov 10Third quarter 2021 earnings releasedThe company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: zł43.6m (down 2.0% from 3Q 2020). Net income: zł165.0k (down 68% from 3Q 2020). Profit margin: 0.4% (down from 1.1% in 3Q 2020). The decrease in margin was driven by lower revenue.
Reported Earnings • Nov 10Third quarter 2021 earnings releasedThe company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: zł43.6m (down 2.0% from 3Q 2020). Net income: zł165.0k (down 68% from 3Q 2020). Profit margin: 0.4% (down from 1.1% in 3Q 2020). The decrease in margin was driven by lower revenue.
Valuation Update With 7 Day Price Move • Jul 18Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to zł6.30, the stock trades at a trailing P/E ratio of 15.4x. Average trailing P/E is 20x in the Consumer Retailing industry in Europe.